Prognostic utility of extranodal disease involvement in diffuse large B-cell lymphoma in patients treated with R-CHOP

被引：0
|
作者：
Hui, David [1 ]
Donaldson, Jane [1 ]
Hoskins, Paul [1 ]
Klasa, Richard [1 ]
Savage, Kerry J. [1 ]
Shenkier, Tamara [1 ]
Gascoyne, Randy D. [2 ]
Connors, Joseph M. [1 ]
Sehn, Laurie [1 ]
机构：
[1] Vancouver Canc Ctr, Dept Med Oncol, Vancouver, BC, Canada
[2] Vancouver Canc Ctr, Dept Pathol, Vancouver, BC, Canada
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1563
引用
收藏
页码：467A / 467A
页数：1
相关论文
共 50 条
  • [31] Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP
    Wang, Yu
    Li, Ya-Jun
    Jiang, Wen-Qi
    Rao, Hui-Lan
    Huang, Jia-Jia
    Xia, Yi
    Bi, Xiwen
    Sun, Peng
    Huang, Hui-Qiang
    Lin, Tong-Yu
    Guan, Zhong-Zhen
    Li, Zhi-Ming
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1865 - 1873
  • [32] Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP
    Kim, Joong-Keun
    Chung, Joo-Seop
    Shin, Ho-Jin
    Song, Moo-Kon
    Yi, Ji-Won
    Shin, Dong-Hun
    Lee, Dae-Sung
    Baek, Sung-Min
    [J]. BLOOD RESEARCH, 2014, 49 (03) : 162 - 169
  • [33] Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy
    Kenjiro Mitsuhashi
    Akihiro Masuda
    Yan-Hua Wang
    Masayuki Shiseki
    Toshiko Motoji
    [J]. International Journal of Hematology, 2014, 100 : 88 - 95
  • [34] The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady
    Chung, Joo-Seop
    Ilic, Ivana
    Leppa, Sirpa
    Seki, Ritsuko
    Uccella, Silvia
    Xia, Zu-Guang
    Butera, James N.
    [J]. BLOOD, 2010, 116 (21) : 1679 - 1679
  • [35] Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy
    Mitsuhashi, Kenjiro
    Masuda, Akihiro
    Wang, Yan-Hua
    Shiseki, Masayuki
    Motoji, Toshiko
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (01) : 88 - 95
  • [36] Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP
    Park, Mi-Jung
    Park, Soon-Ho
    Park, Pil-Whan
    Seo, Yiel-Hea
    Kim, Kyung-Hee
    Seo, Ja-Young
    Jeong, Ji-Hun
    Kim, Moon Jin
    Ahn, Jeong-Yeal
    Hong, Junshik
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (09) : 733 - 738
  • [37] Prognostic Significance Of Systemic Inflammatory Factors In Patients With Diffuse Large B Cell Lymphoma Treated By R-CHOP
    Yoh, Kyung Ah
    Lee, Ho Sup
    Park, Lee Chun
    Lee, Eun Mi
    Shin, Seong Hoon
    Ye, Byeong Jin
    Moon, Joon Ho
    Jo, Jae-Cheol
    Lee, Won Sik
    Shin, Ho-Jin
    Oh, Sun Young
    Kim, Yang Soo
    [J]. BLOOD, 2013, 122 (21)
  • [38] Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma
    Camus, Vincent
    Tilly, Herve
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (12) : 1047 - 1055
  • [39] Primary Cutaneous Diffuse Large B-cell Lymphoma Successfully Treated With R-CHOP Chemotherapy
    Alghamdi, Wafa M.
    Aljehani, Fawaz H.
    Alharthi, Abdullah M.
    Bakhsh, Reda I.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [40] Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge
    Lavacchi, Daniele
    Landini, Ida
    Perrone, Gabriele
    Roviello, Giandomenico
    Mini, Enrico
    Nobili, Stefania
    [J]. PHARMACOLOGY & THERAPEUTICS, 2022, 229
12345